Cargando…

Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy

BACKGROUND: Skeletal muscle mass and strength diminish during periods of disuse but recover upon return to weight bearing in healthy adults but are incomplete in old muscle. Efforts to improve muscle recovery in older individuals commonly aim at increasing myofibrillar protein synthesis via mammalia...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuqua, Jordan D., Lawrence, Marcus M., Hettinger, Zachary R., Borowik, Agnieszka K., Brecheen, Parker L., Szczygiel, Marcelina M., Abbott, Claire B., Peelor, Frederick F., Confides, Amy L., Kinter, Michael, Bodine, Sue C., Dupont‐Versteegden, Esther E., Miller, Benjamin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570113/
https://www.ncbi.nlm.nih.gov/pubmed/37448295
http://dx.doi.org/10.1002/jcsm.13285
_version_ 1785119689726230528
author Fuqua, Jordan D.
Lawrence, Marcus M.
Hettinger, Zachary R.
Borowik, Agnieszka K.
Brecheen, Parker L.
Szczygiel, Marcelina M.
Abbott, Claire B.
Peelor, Frederick F.
Confides, Amy L.
Kinter, Michael
Bodine, Sue C.
Dupont‐Versteegden, Esther E.
Miller, Benjamin F.
author_facet Fuqua, Jordan D.
Lawrence, Marcus M.
Hettinger, Zachary R.
Borowik, Agnieszka K.
Brecheen, Parker L.
Szczygiel, Marcelina M.
Abbott, Claire B.
Peelor, Frederick F.
Confides, Amy L.
Kinter, Michael
Bodine, Sue C.
Dupont‐Versteegden, Esther E.
Miller, Benjamin F.
author_sort Fuqua, Jordan D.
collection PubMed
description BACKGROUND: Skeletal muscle mass and strength diminish during periods of disuse but recover upon return to weight bearing in healthy adults but are incomplete in old muscle. Efforts to improve muscle recovery in older individuals commonly aim at increasing myofibrillar protein synthesis via mammalian target of rapamycin (mTOR) stimulation despite evidence demonstrating that old muscle has chronically elevated levels of mammalian target of rapamycin complex 1 (mTORC1) activity. We hypothesized that protein synthesis is higher in old muscle than adult muscle, which contributes to a proteostatic stress that impairs recovery. METHODS: We unloaded hindlimbs of adult (10‐month) and old (28‐month) F344BN rats for 14 days to induce atrophy, followed by reloading up to 60 days with deuterium oxide (D(2)O) labelling to study muscle regrowth and proteostasis. RESULTS: We found that old muscle has limited recovery of muscle mass during reloading despite having higher translational capacity and myofibrillar protein synthesis (0.029 k/day ± 0.002 vs. 0.039 k/day ± 0.002, P < 0.0001) than adult muscle. We showed that collagen protein synthesis was not different (0.005 k (1/day) ± 0.0005 vs. 0.004 k (1/day) ± 0.0005, P = 0.15) in old compared to adult, but old muscle had higher collagen concentration (4.5 μg/mg ± 1.2 vs. 9.8 μg/mg ± 0.96, P < 0.01), implying that collagen breakdown was slower in old muscle than adult muscle. This finding was supported by old muscle having more insoluble collagen (4.0 ± 1.1 vs. 9.2 ± 0.9, P < 0.01) and an accumulation of advanced glycation end products (1.0 ± 0.06 vs. 1.5 ± 0.08, P < 0.001) than adult muscle during reloading. Limited recovery of muscle mass during reloading is in part due to higher protein degradation (0.017 1/t ± 0.002 vs. 0.028 1/t ± 0.004, P < 0.05) and/or compromised proteostasis as evidenced by accumulation of ubiquitinated insoluble proteins (1.02 ± 0.06 vs. 1.22 ± 0.06, P < 0.05). Last, we showed that synthesis of individual proteins related to protein folding/refolding, protein degradation and neural‐related biological processes was higher in old muscle during reloading than adult muscle. CONCLUSIONS: Our data suggest that the failure of old muscle to recover after disuse is not due to limitations in the ability to synthesize myofibrillar proteins but because of other impaired proteostatic mechanisms (e.g., protein folding and degradation). These data provide novel information on individual proteins that accumulate in protein aggregates after disuse and certain biological processes such as protein folding and degradation that likely play a role in impaired recovery. Therefore, interventions to enhance regrowth of old muscle after disuse should be directed towards the identified impaired proteostatic mechanisms and not aimed at increasing protein synthesis.
format Online
Article
Text
id pubmed-10570113
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105701132023-10-14 Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy Fuqua, Jordan D. Lawrence, Marcus M. Hettinger, Zachary R. Borowik, Agnieszka K. Brecheen, Parker L. Szczygiel, Marcelina M. Abbott, Claire B. Peelor, Frederick F. Confides, Amy L. Kinter, Michael Bodine, Sue C. Dupont‐Versteegden, Esther E. Miller, Benjamin F. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Skeletal muscle mass and strength diminish during periods of disuse but recover upon return to weight bearing in healthy adults but are incomplete in old muscle. Efforts to improve muscle recovery in older individuals commonly aim at increasing myofibrillar protein synthesis via mammalian target of rapamycin (mTOR) stimulation despite evidence demonstrating that old muscle has chronically elevated levels of mammalian target of rapamycin complex 1 (mTORC1) activity. We hypothesized that protein synthesis is higher in old muscle than adult muscle, which contributes to a proteostatic stress that impairs recovery. METHODS: We unloaded hindlimbs of adult (10‐month) and old (28‐month) F344BN rats for 14 days to induce atrophy, followed by reloading up to 60 days with deuterium oxide (D(2)O) labelling to study muscle regrowth and proteostasis. RESULTS: We found that old muscle has limited recovery of muscle mass during reloading despite having higher translational capacity and myofibrillar protein synthesis (0.029 k/day ± 0.002 vs. 0.039 k/day ± 0.002, P < 0.0001) than adult muscle. We showed that collagen protein synthesis was not different (0.005 k (1/day) ± 0.0005 vs. 0.004 k (1/day) ± 0.0005, P = 0.15) in old compared to adult, but old muscle had higher collagen concentration (4.5 μg/mg ± 1.2 vs. 9.8 μg/mg ± 0.96, P < 0.01), implying that collagen breakdown was slower in old muscle than adult muscle. This finding was supported by old muscle having more insoluble collagen (4.0 ± 1.1 vs. 9.2 ± 0.9, P < 0.01) and an accumulation of advanced glycation end products (1.0 ± 0.06 vs. 1.5 ± 0.08, P < 0.001) than adult muscle during reloading. Limited recovery of muscle mass during reloading is in part due to higher protein degradation (0.017 1/t ± 0.002 vs. 0.028 1/t ± 0.004, P < 0.05) and/or compromised proteostasis as evidenced by accumulation of ubiquitinated insoluble proteins (1.02 ± 0.06 vs. 1.22 ± 0.06, P < 0.05). Last, we showed that synthesis of individual proteins related to protein folding/refolding, protein degradation and neural‐related biological processes was higher in old muscle during reloading than adult muscle. CONCLUSIONS: Our data suggest that the failure of old muscle to recover after disuse is not due to limitations in the ability to synthesize myofibrillar proteins but because of other impaired proteostatic mechanisms (e.g., protein folding and degradation). These data provide novel information on individual proteins that accumulate in protein aggregates after disuse and certain biological processes such as protein folding and degradation that likely play a role in impaired recovery. Therefore, interventions to enhance regrowth of old muscle after disuse should be directed towards the identified impaired proteostatic mechanisms and not aimed at increasing protein synthesis. John Wiley and Sons Inc. 2023-07-14 /pmc/articles/PMC10570113/ /pubmed/37448295 http://dx.doi.org/10.1002/jcsm.13285 Text en © 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Fuqua, Jordan D.
Lawrence, Marcus M.
Hettinger, Zachary R.
Borowik, Agnieszka K.
Brecheen, Parker L.
Szczygiel, Marcelina M.
Abbott, Claire B.
Peelor, Frederick F.
Confides, Amy L.
Kinter, Michael
Bodine, Sue C.
Dupont‐Versteegden, Esther E.
Miller, Benjamin F.
Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
title Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
title_full Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
title_fullStr Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
title_full_unstemmed Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
title_short Impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
title_sort impaired proteostatic mechanisms other than decreased protein synthesis limit old skeletal muscle recovery after disuse atrophy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570113/
https://www.ncbi.nlm.nih.gov/pubmed/37448295
http://dx.doi.org/10.1002/jcsm.13285
work_keys_str_mv AT fuquajordand impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT lawrencemarcusm impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT hettingerzacharyr impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT borowikagnieszkak impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT brecheenparkerl impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT szczygielmarcelinam impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT abbottclaireb impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT peelorfrederickf impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT confidesamyl impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT kintermichael impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT bodinesuec impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT dupontversteegdenesthere impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy
AT millerbenjaminf impairedproteostaticmechanismsotherthandecreasedproteinsynthesislimitoldskeletalmusclerecoveryafterdisuseatrophy